Global Biologics and Biosimilars Market Research Report Forecast 2017-2021

March 2017 | 110 pages | ID: G49383F03C8EN
S&P Consulting

Abstracts

The Global Biologics and Biosimilars Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Biologics and Biosimilars industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as applicable). The research analysts provide an elaborate description of the value chain and its distributor analysis. This Biologics and Biosimilars market study provides comprehensive data which enhances the understanding, scope and application of this report.

This report provides comprehensive analysis of

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

Global Biologics and Biosimilars Market: Regional Segment Analysis

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

The Major players reported in the market include:
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
company 9
Global Biologics and Biosimilars Market: Product Segment Analysis
Biologics
Biosimilars

• Type III

Global Biologics and Biosimilars Market: Application Segment Analysis
Tumor
Diabetes
Cardiovascular

REASONS FOR BUYING THIS REPORT

This report provides pin-point analysis for changing competitive dynamics

• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

Contents

CHAPTER 1 BIOLOGICS AND BIOSIMILARS MARKET OVERVIEW

1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Biologics and Biosimilars Market Segmentation by Type
  1.2.1 Global Production Market Share of Biologics and Biosimilars by Type in 2015
  1.2.1 Biologics
  1.2.2 Biosimilars
  1.2.3 Type III
1.3 Biologics and Biosimilars Market Segmentation by Application
  1.3.1 Biologics and Biosimilars Consumption Market Share by Application in 2015
  1.3.2 Tumor
  1.3.3 Diabetes
  1.3.4 Cardiovascular
1.4 Biologics and Biosimilars Market Segmentation by Regions
  1.4.1 North America
  1.4.2 China
  1.4.3 Europe
  1.4.4 Southeast Asia
  1.4.5 Japan
  1.4.6 India
1.5 Global Market Size (Value) of Biologics and Biosimilars (2012-2021)

CHAPTER 2 GLOBAL ECONOMIC IMPACT ON BIOLOGICS AND BIOSIMILARS INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

CHAPTER 3 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET COMPETITION BY MANUFACTURERS

3.1 Global Biologics and Biosimilars Production and Share by Manufacturers (2015 and 2016)
3.2 Global Biologics and Biosimilars Revenue and Share by Manufacturers (2015 and 2016)
3.3 Global Biologics and Biosimilars Average Price by Manufacturers (2015 and 2016)
3.4 Manufacturers Biologics and Biosimilars Manufacturing Base Distribution, Production Area and Product Type
3.5 Biologics and Biosimilars Market Competitive Situation and Trends
  3.5.1 Biologics and Biosimilars Market Concentration Rate
  3.5.2 Biologics and Biosimilars Market Share of Top 3 and Top 5 Manufacturers
  3.5.3 Mergers & Acquisitions, Expansion

CHAPTER 4 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION, REVENUE (VALUE) BY REGION (2012-2017)

4.1 Global Biologics and Biosimilars Production by Region (2012-2017)
4.2 Global Biologics and Biosimilars Production Market Share by Region (2012-2017)
4.3 Global Biologics and Biosimilars Revenue (Value) and Market Share by Region (2012-2017)
4.4 Global Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
4.5 North America Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
4.6 Europe Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
4.7 China Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
4.8 Japan Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
4.9 Southeast Asia Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
4.10 India Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)

CHAPTER 5 GLOBAL BIOLOGICS AND BIOSIMILARS SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2012-2017)

5.1 Global Biologics and Biosimilars Consumption by Regions (2012-2017)
5.2 North America Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)
5.3 Europe Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)
5.4 China Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)
5.5 Japan Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)
5.6 Southeast Asia Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)
5.7 India Biologics and Biosimilars Production, Consumption, Export, Import by Regions (2012-2017)

CHAPTER 6 GLOBAL BIOLOGICS AND BIOSIMILARS PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

6.1 Global Biologics and Biosimilars Production and Market Share by Type (2012-2017)
6.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
6.3 Global Biologics and Biosimilars Price by Type (2012-2017)
6.4 Global Biologics and Biosimilars Production Growth by Type (2012-2017)

CHAPTER 7 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET ANALYSIS BY APPLICATION

7.1 Global Biologics and Biosimilars Consumption and Market Share by Application (2012-2017)
7.2 Global Biologics and Biosimilars Consumption Growth Rate by Application (2012-2017)
7.3 Market Drivers and Opportunities
  7.3.1 Potential Applications
  7.3.2 Emerging Markets/Countries

CHAPTER 8 GLOBAL BIOLOGICS AND BIOSIMILARS MANUFACTURERS ANALYSIS

8.1 Pfizer
  8.1.1 Company Basic Information, Manufacturing Base and Competitors
  8.1.2 Product Type, Application and Specification
  8.1.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.1.4 Business Overview
8.2 Roche
  8.2.1 Company Basic Information, Manufacturing Base and Competitors
  8.2.2 Product Type, Application and Specification
  8.2.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.2.4 Business Overview
8.3 Amgen
  8.3.1 Company Basic Information, Manufacturing Base and Competitors
  8.3.2 Product Type, Application and Specification
  8.3.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.3.4 Business Overview
8.4 AbbVie
  8.4.1 Company Basic Information, Manufacturing Base and Competitors
  8.4.2 Product Type, Application and Specification
  8.4.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.4.4 Business Overview
8.5 Sanofi
  8.5.1 Company Basic Information, Manufacturing Base and Competitors
  8.5.2 Product Type, Application and Specification
  8.5.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.5.4 Business Overview
8.6 Johnson & Johnson
  8.6.1 Company Basic Information, Manufacturing Base and Competitors
  8.6.2 Product Type, Application and Specification
  8.6.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.6.4 Business Overview
8.7 Novo Nordisk
  8.7.1 Company Basic Information, Manufacturing Base and Competitors
  8.7.2 Product Type, Application and Specification
  8.7.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.7.4 Business Overview
8.8 Novartis
  8.8.1 Company Basic Information, Manufacturing Base and Competitors
  8.8.2 Product Type, Application and Specification
  8.8.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.8.4 Business Overview
8.9 company
  8.9.1 Company Basic Information, Manufacturing Base and Competitors
  8.9.2 Product Type, Application and Specification
  8.9.3 Production, Revenue, Price and Gross Margin (2012-2017)
  8.9.4 Business Overview
…

CHAPTER 9 BIOLOGICS AND BIOSIMILARS MANUFACTURING COST ANALYSIS

9.1 Biologics and Biosimilars Key Raw Materials Analysis
  9.1.1 Key Raw Materials
  9.1.2 Price Trend of Key Raw Materials
  9.1.3 Key Suppliers of Raw Materials
  9.1.4 Market Concentration Rate of Raw Materials
9.2 Proportion of Manufacturing Cost Structure
  9.2.1 Raw Materials
  9.2.2 Labor Cost
  9.2.3 Manufacturing Expenses
9.3 Manufacturing Process Analysis of Biologics and Biosimilars

CHAPTER 10 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

10.1 Biologics and Biosimilars Industrial Chain Analysis
10.2 Upstream Raw Materials Sourcing
10.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
10.4 Downstream Buyers

CHAPTER 11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

CHAPTER 12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

CHAPTER 13 GLOBAL BIOLOGICS AND BIOSIMILARS MARKET FORECAST (2017-2021)

13.1 Global Biologics and Biosimilars Production, Revenue Forecast (2017-2021)
13.2 Global Biologics and Biosimilars Production, Consumption Forecast by Regions (2017-2021)
13.3 Global Biologics and Biosimilars Production Forecast by Type (2017-2021)
13.4 Global Biologics and Biosimilars Consumption Forecast by Application (2017-2021)
13.5 Biologics and Biosimilars Price Forecast (2017-2021)

CHAPTER 14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Biologics and Biosimilars
Figure Global Production Market Share of Biologics and Biosimilars by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Biologics and Biosimilars Consumption Market Share by Application in 2015
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure North America Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Figure China Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Figure Japan Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Figure Southeast Asia Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Figure India Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2021)
Figure Global Biologics and Biosimilars Revenue (Million UDS) and Growth Rate (2012-2021)
Table Global Biologics and Biosimilars Capacity of Key Manufacturers (2015 and 2016)
Table Global Biologics and Biosimilars Capacity Market Share by Manufacturers (2015 and 2016)
Figure Global Biologics and Biosimilars Capacity of Key Manufacturers in 2015
Figure Global Biologics and Biosimilars Capacity of Key Manufacturers in 2016
Table Global Biologics and Biosimilars Production of Key Manufacturers (2015 and 2016)
Table Global Biologics and Biosimilars Production Share by Manufacturers (2015 and 2016)
Figure 2015 Biologics and Biosimilars Production Share by Manufacturers
Figure 2016 Biologics and Biosimilars Production Share by Manufacturers
Table Global Biologics and Biosimilars Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Biologics and Biosimilars Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table 2016 Global Biologics and Biosimilars Revenue Share by Manufacturers
Table Global Market Biologics and Biosimilars Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Biologics and Biosimilars Average Price of Key Manufacturers in 2015
Table Manufacturers Biologics and Biosimilars Manufacturing Base Distribution and Sales Area
Table Manufacturers Biologics and Biosimilars Product Type
Figure Biologics and Biosimilars Market Share of Top 3 Manufacturers
Figure Biologics and Biosimilars Market Share of Top 5 Manufacturers
Table Global Biologics and Biosimilars Capacity by Regions (2012-2017)
Figure Global Biologics and Biosimilars Capacity Market Share by Regions (2012-2017)
Figure Global Biologics and Biosimilars Capacity Market Share by Regions (2012-2017)
Figure 2015 Global Biologics and Biosimilars Capacity Market Share by Regions
Table Global Biologics and Biosimilars Production by Regions (2012-2017)
Figure Global Biologics and Biosimilars Production and Market Share by Regions (2012-2017)
Figure Global Biologics and Biosimilars Production Market Share by Regions (2012-2017)
Figure 2015 Global Biologics and Biosimilars Production Market Share by Regions
Table Global Biologics and Biosimilars Revenue by Regions (2012-2017)
Table Global Biologics and Biosimilars Revenue Market Share by Regions (2012-2017)
Table 2015 Global Biologics and Biosimilars Revenue Market Share by Regions
Table Global Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table North America Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Europe Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table China Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Japan Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Southeast Asia Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table India Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Global Biologics and Biosimilars Consumption Market by Regions (2012-2017)
Table Global Biologics and Biosimilars Consumption Market Share by Regions (2012-2017)
Figure Global Biologics and Biosimilars Consumption Market Share by Regions (2012-2017)
Figure 2015 Global Biologics and Biosimilars Consumption Market Share by Regions
Table North America Biologics and Biosimilars Production, Consumption, Import & Export (2012-2017)
Table Europe Biologics and Biosimilars Production, Consumption, Import & Export (2012-2017)
Table China Biologics and Biosimilars Production, Consumption, Import & Export (2012-2017)
Table Japan Biologics and Biosimilars Production, Consumption, Import & Export (2012-2017)
Table Southeast Asia Biologics and Biosimilars Production, Consumption, Import & Export (2012-2017)
Table India Biologics and Biosimilars Production, Consumption, Import & Export (2012-2017)
Table Global Biologics and Biosimilars Production by Type (2012-2017)
Table Global Biologics and Biosimilars Production Share by Type (2012-2017)
Figure Production Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure 2015 Production Market Share of Biologics and Biosimilars by Type
Table Global Biologics and Biosimilars Revenue by Type (2012-2017)
Table Global Biologics and Biosimilars Revenue Share by Type (2012-2017)
Figure Production Revenue Share of Biologics and Biosimilars by Type (2012-2017)
Figure 2015 Revenue Market Share of Biologics and Biosimilars by Type
Table Global Biologics and Biosimilars Price by Type (2012-2017)
Figure Global Biologics and Biosimilars Production Growth by Type (2012-2017)
Table Global Biologics and Biosimilars Consumption by Application (2012-2017)
Table Global Biologics and Biosimilars Consumption Market Share by Application (2012-2017)
Figure Global Biologics and Biosimilars Consumption Market Share by Application in 2015
Table Global Biologics and Biosimilars Consumption Growth Rate by Application (2012-2017)
Figure Global Biologics and Biosimilars Consumption Growth Rate by Application (2012-2017)
Table Pfizer Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Pfizer Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Pfizer Biologics and Biosimilars Market Share (2012-2017)
Table Roche Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Roche Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Roche Biologics and Biosimilars Market Share (2012-2017)
Table Amgen Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Amgen Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Amgen Biologics and Biosimilars Market Share (2012-2017)
Table AbbVie Basic Information, Manufacturing Base, Production Area and Its Competitors
Table AbbVie Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table AbbVie Biologics and Biosimilars Market Share (2012-2017)
Table Sanofi Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Sanofi Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Sanofi Biologics and Biosimilars Market Share (2012-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Johnson & Johnson Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Johnson & Johnson Biologics and Biosimilars Market Share (2012-2017)
Table Novo Nordisk Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novo Nordisk Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Novo Nordisk Biologics and Biosimilars Market Share (2012-2017)
Table Novartis Basic Information, Manufacturing Base, Production Area and Its Competitors
Table Novartis Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table Novartis Biologics and Biosimilars Market Share (2012-2017)
Table company 9 Basic Information, Manufacturing Base, Production Area and Its Competitors
Table company 9 Biologics and Biosimilars Production, Revenue, Price and Gross Margin (2012-2017)
Table company 9 Biologics and Biosimilars Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2015
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure Global Biologics and Biosimilars Production and Growth Rate Forecast (2017-2021)
Figure Global Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2021)
Table Global Biologics and Biosimilars Production Forecast by Regions (2017-2021)
Table Global Biologics and Biosimilars Consumption Forecast by Regions (2017-2021)
Table Global Biologics and Biosimilars Production Forecast by Type (2017-2021)
Table Global Biologics and Biosimilars Consumption Forecast by Application (2017-2021)